![John Friend](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Friend
Directeur Général chez
KAZIA THERAPEUTICS LIMITED
Fortune : 150 $ au 31/05/2026
Profil
John E.
Friend is Chief Executive Officer & Director at Kazia Therapeutics Ltd. since 2024.
Formerly, Senior Vice President-Medical & Scientific Affairs at Helsinn Therapeutics (U.S.), Inc. from 2010 to 2017.
Chief Medical Officer & Vice President at Cellectar Biosciences, Inc. from 2017 to 2018 and again from 2020 to 2021.
Chief Medical Officer at Druggability Technologies Holdings Ltd. (New Jersey).
Education includes undergraduate studies at Southern Methodist University and a doctorate from Robert Wood Johnson Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KAZIA THERAPEUTICS LTD 0,26 % | 18/03/2026 | 15 000 000 ( 0,26 % ) | 150 $ | 31/05/2026 |
Postes actifs de John Friend
| Sociétés | Poste | Début |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Directeur Général | 01/05/2023 |
Anciens postes connus de John Friend
| Sociétés | Poste | Fin |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 02/11/2021 |
| CELLECTAR BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 27/11/2018 |
Helsinn Therapeutics (U.S.), Inc.
 Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Directeur Technique/Scientifique/R&D | 01/04/2017 |
Druggability Technologies Holdings Ltd. (New Jersey) | Directeur Technique/Scientifique/R&D | - |
Formation de John Friend
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Kazia Therapeutics Ltd.
 Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Southern Methodist University
 Southern Methodist University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products for treatment of cancer | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Druggability Technologies Holdings Ltd. (New Jersey) |
Choisissez Zonebourse 
